WisdomTree Adjusts Fees for Its Triple-Leveraged Nasdaq 100 Inverse ETF

WisdomTree revises stock borrowing fees for its 3x Daily Short Nasdaq 100 ETP, effective April 2026, impacting leveraged bearish bets amid a tech correction.

Investors utilizing the WisdomTree NASDAQ 100 3x Daily Short exchange-traded product (ETP) for leveraged bearish bets are facing revised cost terms. The issuer has formally amended the stock borrowing fees, effective April 1, 2026, a move that coincides with a turbulent period for the technology-heavy Nasdaq 100 index.

Market Context: A Tech Correction Underway

The timing of this structural adjustment is notable. The Nasdaq 100 has officially entered correction territory, having retreated approximately 11% from its October peak. Market analysts point to a combination of factors driving the sell-off: signs of exhaustion in the artificial intelligence (AI) trade and escalating geopolitical tensions in the Middle East. While major tech firms continue to forecast profit growth, skepticism is mounting regarding the ultimate profitability of the massive capital expenditures required for AI infrastructure.

This volatile backdrop is where the ETP operates. Designed to deliver three times the inverse daily performance of the Nasdaq 100, its efficiency is directly impacted by financing costs like the stock borrow rate.

The Specific Cost Change

The ETP’s swap counterparty, BNP Paribas, is implementing the change. The revised "Stock Borrow Rate" has been formalized through a supplement to the trust deed. These costs are integrated directly into the product's daily performance calculation. For a tactical short instrument with triple leverage, even minor adjustments to such embedded costs can influence the net return for holders.

The WisdomTree NASDAQ 100 3x Daily Short currently manages assets of roughly €113 million. The instrument's price action this week highlights its speculative nature. On Tuesday, it declined 9.57% to €3.03, following a surge that had pushed it to a new 52-week high of €3.36 just the day before.

A Tool for Short-Term Tactics, Not Long-Term Holding

This price volatility underscores the product's intended use. Due to the daily rebalancing of its leverage factor, it remains primarily a vehicle for short-term market views. It is generally considered unsuitable as a core, long-term holding in an investment portfolio.

Market participants are now closely watching key technical levels for the underlying Nasdaq 100 index, notably the psychological support zones at 22,500 and 20,000 points. Meanwhile, the new stock lending terms will begin affecting the daily return calculation of this short instrument, subtly altering the cost of maintaining a position.